Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa

NCT01399515 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01399515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
November 30, 2015
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eye disease, hereditary, eye diseases, retinal degeneration, retinal diseases, retinitis pigmentosa